“We Need More Competition And Not Less To Address This Pandemic” WASHINGTON, D.C. – The Coalition Against Patent Abuse (CAPA) released the following statement regarding today’s announcement by Gilead that it is withdrawing its request for extended monopoly rights on potential Covid-19 treatment remdesivir and will ask the FDA to revoke the drug’s special “orphan drug” […]

Continue Reading

President Trump Addressed the Need for Affordable Generic Drugs at the SOTU, Patent Reform is a Critical Component WASHINGTON, D.C. – The Coalition Against Patent Abuse (CAPA) released the following statement regarding the Trump administration’s efforts to tackle rising prescription drug prices caused by big pharmaceutical companies in his 2020 State of the Union address to […]

Continue Reading

Presidential Candidate Mike Bloomberg Proposes New Patent Reform Plan to Implement Long Overdue Patent Reforms IN CASE YOU MISSED IT: The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free-market advocates and others released the following statement today regarding presidential candidate Mike Bloomberg’s new drug pricing plan that would […]

Continue Reading

Urges Congress to Put Patients First and Finally Act on Long Overdue Patent Reforms WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free-market advocates and others released the following statement today regarding a last-minute provision slipped into the $1.4 trillion spending bill without any hearings […]

Continue Reading

Urges Representatives to Take Further Measures Toward Ending Big Pharma’s Patent Abuse WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free-market advocates and others released the following statement commending the House Judiciary Committee for voting, on a bipartisan basis, to advance theAffordable Prescriptions for […]

Continue Reading

Commends Senator Tillis and the Senate Judiciary Subcommittee on Intellectual Property for holding hearing & shining a light on the important issue of low-quality and invalid patents. WASHINGTON, D.C. –  The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates and others released the following statement […]

Continue Reading

Commends Committee members for exposing Big Pharma’s efforts to abuse the U.S. patent system & deny patient access to more affordable generic medications and life-saving treatments WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free-market advocates and others released the following statement today in response […]

Continue Reading

Coalition organizes letter to Senators Coons and Tillis expressing significant concern that the STRONGER Patents Act would embolden Big Pharma to continue abusing the patent system and continue raising prices on prescription drugs WASHINGTON, D.C. –  Ahead of today’s Senate Judiciary Subcommittee hearing on the STRONGER Patents Act of 2019, over 20 organizations from across […]

Continue Reading

Bipartisan Effort Grows to Stop Big Pharma From Gaming System & Price-Gouging Patients WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates and others, today announced that the Niskanen Center has joined its organization:  “The Niskanen Center is a welcome addition to […]

Continue Reading

Thanks Committee members for highlighting the damaging impact of Big Pharma’s abuse of the U.S. patent system to maintain drug monopolies and prevent or delay generic alternative medications and life-saving treatments for patients WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates […]

Continue Reading